Thijssen JH - Search Results

1

CYP19 gene expression and aromatase activity in endometrial cancer tissue: importance of the type of the disease.

Berstein L, Zimarina T, Kovalevskij A, Maximov S, Volkov O, Thijssen JH. Berstein L, et al. Among authors: thijssen jh. Neoplasma. 2005;52(2):115-8. Neoplasma. 2005. PMID: 15800709

2

Hormonal imbalance in two types of endometrial cancer and genetic polymorphism of steroidogenic enzymes.

Berstein L, Zimarina T, Imyanitov E, Kovalevskij A, Maximov S, Pujol P, Thijssen J. Berstein L, et al. Maturitas. 2006 Jul 20;54(4):352-5. doi: 10.1016/j.maturitas.2006.04.017. Epub 2006 May 30. Maturitas. 2006. PMID: 16730930

3

CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity.

Berstein LM, Imyanitov EN, Kovalevskij AJ, Maximov SJ, Vasilyev DA, Buslov KG, Sokolenko AP, Iyevleva AG, Chekmariova EV, Thijssen JH. Berstein LM, et al. Among authors: thijssen jh. Cancer Lett. 2004 Apr 30;207(2):191-6. doi: 10.1016/j.canlet.2004.01.001. Cancer Lett. 2004. PMID: 15072828

4

The relationship between aromatase in primary breast tumors and response to treatment with aromatase inhibitors in advanced disease.

de Jong PC, Blankenstein MA, Nortier JW, Slee PH, van de Ven J, van Gorp JM, Elbers JR, Schipper ME, Blijham GH, Thijssen JH, Lu Q, Jelovac D, Brodie AM. de Jong PC, et al. Among authors: thijssen jh. J Steroid Biochem Mol Biol. 2003 Nov;87(2-3):149-55. doi: 10.1016/j.jsbmb.2003.09.012. J Steroid Biochem Mol Biol. 2003. PMID: 14672735

5

Importance of local aromatase activity in hormone-dependent breast cancer: a review.

de Jong PC, Blankenstein MA, van de Ven J, Nortier JW, Blijham GH, Thijssen JH. de Jong PC, et al. Among authors: thijssen jh. Breast. 2001 Apr;10(2):91-9. doi: 10.1054/brst.2000.0209. Breast. 2001. PMID: 14965567

6

Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole.

de Jong PC, van de Ven J, Nortier HW, Maitimu-Smeele I, Donker TH, Thijssen JH, Slee PH, Blankenstein RA. de Jong PC, et al. Among authors: thijssen jh. Cancer Res. 1997 Jun 1;57(11):2109-11. Cancer Res. 1997. PMID: 9187104 Clinical Trial.

7

Aromatase and COX-2 expression in human breast cancers.

Brodie AM, Lu Q, Long BJ, Fulton A, Chen T, Macpherson N, DeJong PC, Blankenstein MA, Nortier JW, Slee PH, van de Ven J, van Gorp JM, Elbers JR, Schipper ME, Blijham GH, Thijssen JH. Brodie AM, et al. Among authors: thijssen jh. J Steroid Biochem Mol Biol. 2001 Dec;79(1-5):41-7. doi: 10.1016/s0960-0760(01)00131-5. J Steroid Biochem Mol Biol. 2001. PMID: 11850206

8

The use of high-dose estrogens for the treatment of breast cancer.

Coelingh Bennink HJ, Verhoeven C, Dutman AE, Thijssen J. Coelingh Bennink HJ, et al. Maturitas. 2017 Jan;95:11-23. doi: 10.1016/j.maturitas.2016.10.010. Epub 2016 Oct 18. Maturitas. 2017. PMID: 27889048 Free article. Review.

9

Endogenous steroid hormones and local aromatase activity in the breast.

Thijssen JH, Blankenstein MA, Donker GH, Daroszewski J. Thijssen JH, et al. J Steroid Biochem Mol Biol. 1991 Nov;39(5B):799-804. doi: 10.1016/0960-0760(91)90028-4. J Steroid Biochem Mol Biol. 1991. PMID: 1954169

10

Intratumoral levels of estrogens in breast cancer.

Blankenstein MA, van de Ven J, Maitimu-Smeele I, Donker GH, de Jong PC, Daroszewski J, Szymczak J, Milewicz A, Thijssen JH. Blankenstein MA, et al. Among authors: thijssen jh. J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):293-7. doi: 10.1016/s0960-0760(99)00048-5. J Steroid Biochem Mol Biol. 1999. PMID: 10419005 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

288 results

Search Page